Document Classification

Section Type: METHODS

Text: NSCLC patients, aged < 75, PS 0-2, who had failed platinum-based chemotherapy, were randomly assigned with a 3:1:1 ratio to : arm A, weekly docetaxel (33. 3 mg/m (2) on days 1, 8, 15 q 4 weeks) ; arm B, weekly docetaxel (30 mg/m (2) on days 1, 8, 15) plus gemcitabine (800 mg/m (2) on days 1, 8 q 4 weeks) or plus vinorelbine (20mg/m (2) on days 1, 8 q 4 weeks) depending on which of the two had been used in first line ; arm C, weekly docetaxel (as in arm B) plus capecitabine (625 mg/m (2) twice daily on days 5-18 q 4 weeks).